Scientific Advisory Board
Scientific Advisory Board 2008
- Dr. Sherif Abou Elela (Scientific director of the LGFUS)
- Dr. Quaid Morris (University of Toronto, Canada)
- Dr. Jane Wu (Splicing regulation, Vanderbilt University Medical Center, USA)
- Dr. Julian Venables (Splicing Coordinator)
- Dr. Karine Tremblay (Lab Coordinator)
- Dr. John M. Burke (Ribozymes, University of Vermont, USA)
- Dr. Jean-Pierre Perreault (ISI Agent Design and Development Group)
- Dr. Mariano A. Garcia-Blanco (Chairman, splicing regulation, Duke University Medical Center, USA)
- Dr. Ryszard Kole (Splicing modulation, University of North Carolina at ChapelHill, USA)
- Dr. Benoit Chabot (RBP Group)
- Dr. Barbara Vanderhyden (Ovarian cancer, University of Ottawa, Canada)
- Dr. John Rossi (siRNA, Research Institute of the City of Hope, USA)
- Dr. Richard Einstein (Splicing technologies, ExonHit Therapeutics Inc., USA)
- Dr. Roscoe Klinck (Director of RNomics Platform)
- Dr. Darel Hunting Département de médecine nucléaire et de radiobiologie, Université de Sherbrooke
- Dr. Pierre Beauparlant (Oncology therapeutics, Gemin X Biotechnologies Inc., Canada)
- Anne-Marie Alarco Génome Québec
- Dr. Panagiotis Prinos (Project Manager)
Absent from the picture
Scientific Advisory Board 2007
Front row
- Dr. Sherif Abou Elela (Scientific director of the LGFUS)
- Dr. Pierre Beauparlant (Oncology therapeutics, Gemin X Biotechnologies Inc., Canada)
- Dr. Barbara Vanderhyden (Ovarian cancer, University of Ottawa, Canada)
- Dr. John M. Burke (Ribozymes, University of Vermont, USA)
- Dr. John Rossi (siRNA, Research Institute of the City of Hope, USA)
- Dr. Claudine Rancourt (Phenotypic Analysis Group)
- Dr. Ryszard Kole (Splicing modulation, University of North Carolina at ChapelHill, USA)
- Dr. Jane Wu (Splicing regulation, Vanderbilt University Medical Center, USA)
Back row
Absent from the picture
Scientific Advisory Board 2006
Front row
- Dr. Jane Wu (Splicing regulation, Vanderbilt University Medical Center, USA)
- Dr. John M. Burke (Ribozymes, University of Vermont, USA)
- Dr. Claudine Rancourt (Phenotypic Analysis Group)
- Dr. Barbara Vanderhyden (Ovarian cancer, University of Ottawa, Canada)
- Ms. Eve-Lyne Mathieu (Lab Coordinator)
- Dr. Ryszard Kole (Splicing modulation, University of North Carolina at ChapelHill, USA)
- Dr. Benjamin J. Blencowe (Alternative splicing arrays, University of Toronto, Canada)
- Dr. Benoit Chabot (RBP Group)
Back row
Absent from the picture
